Pharmacological and Behavioral Treatment After Bariatric Surgery

NCT05157698 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Naltrexone and Bupropion Combination
BEHAVIORAL: Behavioral Weight Loss
OTHER: Placebo

Sponsor

Yale University

Collaborators

[object Object]